Parathyroid hormone and dialysis quality in kidney failure patients
Part of Hormones & metabolism, Kidney & urinary, Women’s health & pregnancy clinical trials.
This study looks at how well dialysis removes waste from the blood and whether it relates to parathyroid hormone levels in people on long-term dialysis. It aims to improve dialysis treatment for people with kidney failure.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must be at least 18 years old.
- You must have end-stage kidney failure and be on regular dialysis (3 times a week) for at least 3 months.
- You do not have primary hyperparathyroidism or have had your parathyroid glands removed.
- You do not have a severe current infection, active cancer, or serious liver disease.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial compares two treatment goals for blood phosphate levels in people with end-stage kidney disease who are on dialysis. It may help determine which target is safer and works better in real-world care.
This study looks at how patients' quality of life changed after they had parathyroidectomy (surgery to remove parathyroid glands) for secondary hyperparathyroidism related to end-stage kidney disease. The goal is to understand the benefits of this surgery for future patients.
This study looks at how well the thyroid gland works in people who are on regular dialysis for kidney failure. By checking thyroid hormone levels, researchers hope to understand thyroid problems in this group and potentially improve their care.
This trial tests a new medicine called MT1013 for people with secondary hyperparathyroidism who are on dialysis. It may help control high parathyroid hormone levels when current treatments are not enough.
This study checks thyroid function in people who are on long-term hemodialysis for kidney failure. It aims to see how common thyroid issues are in this group, which could help improve care.
This trial tests whether regulating parathyroid hormone (PTH) can improve bone density in people with advanced chronic kidney disease (CKD) who are not on dialysis. It may help you if you have stage 4-5 CKD and high PTH levels.
Hear when a new Kidney Failure, Chronic trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.